Your Article Summary
Febuxostat for hyperuricemia in patients with gout
American Pharmacists Association, 03/18/09
Schuna A et al. - Two recently published studies examined the efficacy and safety of febuxostat, which was recently approved for the chronic management of hyperuricemia in patients with gout. The approval of this product marks the first new treatment option for the chronic management of this condition in more than 40 years.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Article Search
Sponsor


See Latest Articles


